CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
78 hedge funds and large institutions have $168M invested in Cascadian Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
78
Holders Change
+21
Holders Change %
+36.84%
% of All Funds
1.94%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
30
Increased
25
Reduced
10
Closed
5
Calls
$741K
Puts
–
Net Calls
+$741K
Net Calls Change
+$202K
